1. Odom B Richard, James D William, Berger G Timoty. Chronic blistering dermatoses. Saunders Adrew's Diseases of The Skin Clinical Dermatology. 2000: 574-605.
2. Fenella Wojnarowska, RAJ. Eady, M Burge. Bullous Eruptions. In (Rook, Wilkinson, Ebling eds.) Text Book of Dermatology. London Blackwell Science, 1998: 1817-1917.
3. Nousari CH , Anhalt GC. Pemfigus and bullous pemfigoid. The Lancet 1999; 354:
667-72.
4.
Memişoğl
u R, Uzun S. İmmünobülloz Dermatozlarda Tedavi. 13. Prof. Dr. A. Lütfü Tat Sempozyumu Kitabı .Ed. Gürgey E. Ankara. Nurol Matbaacılık. 1997:
99-116.
5. Bystry JC, Steinmen NM. The adjuvan therapy of pemfigus. Arch. Dermatol 1996;
132: 203-212.
6.
Tüzü
n Y. MAT M. C Büllü Hastalıklar. In (Tüzün Y, Katoğyan A, Aydemir E H, Baransü O. eds.) Dermatoloji. İstanbul, Nobel Tıp Kitabevi. 1994: 353-377.
7. Dumas
V
, Roujeau JC, Wolkenstein P, Revuz J, Cosnes A. The treatment of pemfigus vulgaris and pemfigus foliaceus with a topical corticosteroid. British
Journal of Dermatology 1999; 140: 1127-1129.
8. Toth GG, Kloosterman C, Uges DR, Jonkman MF. Pharmacokinetics of high-dose and intravenous dexametason. Ther Drug Monit 1999; 21(5): 532-5.
9. Roujeau JC. Pulse glucocorticoid therapy. The " big shot' revisited . Arch
Dermatol 1996; 132(12): 1499-502.
10. Warth PV. Pulse cylophosphamid for treatment of autoimmun blistering disease:
Arch Dermatol 1997; 133: 229-230.
11. Roujeu J C. Pulse Glucocorticoid therapy. Arch Dermatol 1996; 132: 1499-1502.
12. Tan BB, Lear JT, Gawkrodger DJ, Engklish JS. Azothioprine in dermatology: a survey of current practice in the UK British Journal of Dermatology 1997; 136 (3):
351-355.
13. Fleischli ME, Valek RH, Pandya AG. Pulse intravenous cyclophosphamid therapy
in pemfigus. Arch Dermatol 1999; 135(1): 57-61.
14. Gooptu C, Staughton RCD. Use of topical cyclosporin in oral pemfigus. J Am
Acad Dermatol 1998; 38: 860-861.
15. Marcella Grudmann-Kollman. Mycophenonolat: A new theraupotic option in the treatment of blistering autoimmun disease. J Am Acad. Dermotol 1999; 40: 957¬960
16. Zwillich T. Try mycophenolate mofetil for though pemfigus, pemfigoid. Skin &
Allergy News 1999; 30(2): 36
17. Nousari HC, Sragovich A, Kimyai Asadi A, Orlinsky D, Anhalt GJ. Mycophenolate mofetil in autoimmun and inflamatory skin disorder. J Am Acad Dermatol 1999;
40: 265-268.
18. Pandya AG, Dyke C. Treatment of pemfigus with gold. Arch Dermatol 1998;
134(9): 1104-1107.
19. Bjanarson B, Skoglund C, Flosadottir E. Childhood pemfigus vulgaris with dapson:
a case report. Pediatr Dermatol 1998; 15(5): 381-383.
20. Calebotta A, Saenz AM, Gonzales F, Carvalho M, Castillo R. Pemfigus vulgaris: benefits of tetracycline as adjuvant therapy in a series thirteen patients. International Journal of Dermatology 1999; 38: 217-221
21. Turner SM, David S :The use of plasmaferesis and immunosupression in the treatment of pemfigus vulgaris J Am Acad. Dermatol. 2000; 43: 1058-1064.
22. Wollina U, Lange D, Looks A. Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases. Dermatology 1999;
198(2): 140-1
23. Yancey BK Pemfigoid: Clinical, histologic, immonopathologic and theuropatic
consideration. Jama 2000; 284: 350-356.
24. Engineer L, Ahmed AR. Role of immunglobulin in the treatment of bullous pemfigoid: analysis of current data. J Am Acad Dermatol 2001; 44: 83-88
25. Fleming E T, Korman N J. Cicatricial pemfigoid. Arch. Dermotol. 2000; 43: 571¬91
26. Pandya GA. Cicatricial pemfigoid succesfully treated with pulse intravenous
cyclophosphamide. Arch. Dermatol. 1997;133:245-247.
27. Megahet M , Schemiedeberg S. The treatment of cicatricial pemfigoid with mycophenolate mofetil as a steroid sparing agent. J. Am. Acad. Dermatol. 2001;
25: 256-59
28. Engineer L, Ahmet AR. Emergine treatment for epidermolysis acquisita. J. Am.
Acad. Dermatol. 2001; 44: 818-28
29. Khan IU, Linear immunglobuJine A bullous dermatosis patient with chronic renal failure: response to intravenous immunglobuline therapy. J. Am. Acad. Dermatol.
199; 40: 485-88
69
Bayram ve Eşrefoğlu
30. Powell J, Kirtcschig. Mixed Immunobullos diseases of childhood: A good response to antimicrobials. British Journal of dermatology. 2001; 144: 769-774
31. Siegfried CE. Chronic bullous diseases of chidhood succesfull treatment with
dicloxacilline. J. Am. Acad. Dermatol. 1998; 39: 797-800
32. Marinkovich MP. Blistering diseases. Electronic textbook of dermatology http://www.telemedicine.or^stamford.htm
33. Marinkovich MP. Diagnosis treatment of blistering disorders enter new era.
Dermatology times 1999; 20(3): 17-19
Thank you for copying data from http://www.arastirmax.com
